FindTrial
Sign In

effect of oral micronized progesterone for prolongation of pregnancy in arrested preterm labour

ORAL MICRONIZED PROGESTERONE FOR MAINTENANCE TOCOLYSIS AFTER ARRESTED PRETERM LABOUR- A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/10/002043
Enrollment
90
Registered
2011-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PRETERM LABOUR

Interventions

Intervention1: ORAL MICRONIZED PROGESTERONE: Cap MICRONIZED PROGESTERONE 200mg OD given orally from time of recruitment till 37 weeks of gestation or delivery whichever is earlier. Control Interventio

Sponsors

UCMS and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: .Only those Pregnant women between 24-34 weeks period of gestation with preterm labour pain .Singleton pregnancy .Intact membrane

Exclusion criteria

Exclusion criteria: .Multiple pregnancy .Premature rupture of membranes .Antepartum hemorrhage .Fetal growth restriction/gross congenital anomalies .Severe maternal illness

Design outcomes

Primary

MeasureTime frame
prolongation of pregnancyTimepoint: NIL—

Secondary

MeasureTime frame
birth weightTimepoint: nil;early neonatal mortalityTimepoint: nil;neonatal morbidityTimepoint: nil;NICU admission rateTimepoint: nil;number of pretem birthTimepoint: nil;readmission for preterm labourTimepoint: NIL—

Countries

India

Contacts

Public ContactDr AMITA SUNEJA

ucms and GTB hospital

amita_suneja@yahoo.co.in9868399728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 8, 2026